Yes, THC (delta-9-tetrahydrocannabinol) is considered a drug by every major legal, medical, and scientific standard. It is the primary psychoactive compound in cannabis, and it meets the definition of a drug under federal law, international treaties, and pharmacology. That said, the full picture is more nuanced than a simple yes or no, because THC’s legal status varies depending on its concentration, its source, and which jurisdiction you’re in.
Why THC Qualifies as a Drug
Under the Federal Food, Drug, and Cosmetic Act, a “drug” is any substance intended to diagnose, cure, treat, or prevent disease, or any substance (other than food) intended to affect the structure or function of the body. THC clearly meets both criteria. It alters brain function, changes mood and perception, affects heart rate, and has recognized therapeutic applications.
From a pharmacological standpoint, THC acts on specific receptors in the brain and body called CB1 and CB2 receptors. CB1 receptors are concentrated in areas of the brain responsible for memory, coordination, pleasure, and thinking. CB2 receptors are found primarily on immune cells. When THC binds to these receptors, it produces measurable physiological changes: altered perception of time, euphoria, increased appetite, reduced nausea, and pain relief. That biological mechanism is what makes any substance a drug in the scientific sense.
Federal Scheduling: Where THC Sits
The U.S. Drug Enforcement Administration classifies marijuana (cannabis) as a Schedule I controlled substance, alongside heroin, LSD, and ecstasy. Schedule I is reserved for substances the federal government defines as having “no currently accepted medical use and a high potential for abuse.” This is the most restrictive category in the Controlled Substances Act.
That classification has been controversial for decades, especially because the FDA has approved multiple pharmaceutical products containing THC or synthetic versions of it. Dronabinol (sold as Marinol and Syndros) is a synthetic form of THC approved to treat chemotherapy-related nausea and vomiting, as well as appetite and weight loss in people with HIV/AIDS. Nabilone (sold as Cesamet) is a synthetic compound similar to THC approved for the same anti-nausea purpose. These medications are prescribed by doctors and dispensed by pharmacies, which puts them squarely in the category of recognized drugs.
The Hemp Loophole
The 2018 Farm Bill created a legal distinction based on THC concentration. Any part of the cannabis plant containing no more than 0.3% delta-9 THC on a dry-weight basis is classified as hemp, not marijuana. Hemp is legal at the federal level. Cannabis containing more than 0.3% delta-9 THC remains a controlled substance under federal law.
This threshold has led to a booming market for hemp-derived products, including delta-8 THC and other cannabinoid variants that exist in a legal gray area. The substance itself doesn’t stop being pharmacologically active at 0.3%. That number is a regulatory line, not a scientific one. Even at low concentrations, THC still binds to the same receptors and produces the same types of effects, just at a lower intensity.
How THC Affects the Body
THC’s effects are dose-dependent, and the threshold for noticeable changes is surprisingly low. Pain relief can begin at doses as small as 2 to 2.5 milligrams, well below the level that produces a “high.” A 10 mg dose typically produces subjective drug effects and elevated heart rate but doesn’t significantly impair thinking or coordination in most people. At 25 to 50 mg, pronounced psychoactive effects set in, along with measurable impairment in cognitive and motor function. The risk of unpleasant effects like anxiety and paranoia also rises sharply at higher doses.
Edible cannabis products are responsible for the majority of emergency room visits tied to cannabis intoxication, largely because they take longer to kick in (sometimes 60 to 90 minutes) and people often consume more than intended while waiting to feel something. A typical therapeutic dose for medical use is around 10 mg of THC per day, and pain relief occurs at blood levels well below those associated with euphoria.
Dependency and Risk
THC carries a real, if moderate, risk of dependency. Among adults who use cannabis, roughly 9 to 15% meet clinical criteria for cannabis use disorder, depending on the diagnostic framework used. That rate has actually decreased over the past two decades even as overall cannabis use has risen significantly. Between 2002 and 2017, past-year cannabis use among U.S. adults climbed from 10.4% to 15.3%, while the rate of moderate to severe cannabis use disorder among users dropped from about 6.7% to 4.4% combined.
Daily or near-daily use has more than doubled during that same period, rising from 1.9% to 4.2% of adults. So while fewer users proportionally develop problematic patterns, the total number of heavy users has grown substantially. Cannabis use disorder involves symptoms like unsuccessful attempts to cut back, continued use despite negative consequences, tolerance (needing more to get the same effect), and withdrawal symptoms such as irritability, sleep problems, and decreased appetite.
International Classification
The World Health Organization has formally reviewed THC and cannabis-related substances through its Expert Committee on Drug Dependence. The WHO acknowledges both the public health risks and the emerging therapeutic value of cannabis-based medicines. Its recommendations aim to balance preventing misuse with allowing legitimate medical access. Delta-9 THC has been the subject of critical review reports, and the WHO’s position supports rescheduling cannabis in ways that reflect its medicinal potential while maintaining safeguards.
Drug Testing and THC
For practical purposes, THC is the compound that standard drug tests look for. Workplace screenings, probation tests, and military drug panels all target THC or its metabolites. Because THC is fat-soluble, it stores in body fat and releases slowly, meaning it can be detected in urine for days to weeks after last use depending on frequency. A single use might clear in three to four days, while daily use can produce positive results for 30 days or longer. This is one of the most common reasons people search for whether THC is “really” a drug: they want to know if it will show up on a test. It will.
Regardless of whether cannabis is legal in your state, THC remains a controlled substance under federal law, and most employer drug policies reflect that federal classification. Even in states with legal recreational cannabis, employers in safety-sensitive industries often retain the right to test for and act on positive THC results.